Pierre-Emmanuel Bonte (Pierre-Emmanuel Bonté)

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 17

Top Topics

Regulatory T Cells

Acute Lymphoblastic Leukemia

Immune Response

Epidermal Growth Factor Receptor

Top Venues

Nature immunology

Nature communications

This page only lists publications with an associated author ORCID identifier.

Publications

Elisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, Rafael Mena Osuna, Jordan Denizeau, Mathieu Maurin, Juan José Sáez, Mabel Jouve, Pierre-Emmanuel Bonte, Wilfrid Richer, Fabien Nevo, Sebastien Lemoine, Nicolas Girard, Marine Lefevre, Edith Borcoman, Anne-Vincent Salomon, Sylvain Baulande, Helene D Moreau, Christine Sedlik, Claire Hivroz, Ana-Maria Lennon-Duménil, Jimena Tosello, Eliane Piaggio
CD74 supports accumulation and function of regulatory T cells in tumors. Nature communications 15 (1) (2024)
Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai, Mac Lean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L Guerin, Joshua J Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory L Beatty, Jennifer L Brogdon, Elizabeth Hexner, Denis Migliorini, Cécile Alanio, Donald M O'Rourke
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nature cancer 5 (3) (2024)
Elisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, Rafael Mena Osuna, Jordan Denizeau, Mathieu Maurin, Juan José Sáez, Mabel Jouve, Pierre-Emmanuel Bonte, Wilfrid Richer, Fabien Nevo, Sebastien Lemoine, Nicolas Girard, Marine Lefevre, Edith Borcoman, Anne-Vincent Salomon, Sylvain Baulande, Helene D Moreau, Christine Sedlik, Claire Hivroz, Ana-Maria Lennon-Duménil, Jimena Tosello, Eliane Piaggio
CD74 supports accumulation and function of regulatory T cells in tumors. Nature communications 15 (1) (2024)
Elisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, Rafael Mena Osuna, Jordan Denizeau, Mathieu Maurin, Juan José Sáez, Mabel Jouve, Pierre-Emmanuel Bonte, Wilfrid Richer, Fabien Nevo, Sebastien Lemoine, Nicolas Girard, Marine Lefevre, Edith Borcoman, Anne-Vincent Salomon, Sylvain Baulande, Helene D Moreau, Christine Sedlik, Claire Hivroz, Ana-Maria Lennon-Duménil, Jimena Tosello, Eliane Piaggio
CD74 supports accumulation and function of regulatory T cells in tumors. Nature communications 15 (1) (2024)
Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai, Mac Lean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L Guerin, Joshua J Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory L Beatty, Jennifer L Brogdon, Elizabeth Hexner, Denis Migliorini, Cécile Alanio, Donald M O'Rourke
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nature cancer 5 (3) (2024)
Elisa Bonnin, Maria Rodrigo Riestra, Federico Marziali, Rafael Mena Osuna, Jordan Denizeau, Mathieu Maurin, Juan José Sáez, Mabel Jouve, Pierre-Emmanuel Bonte, Wilfrid Richer, Fabien Nevo, Sebastien Lemoine, Nicolas Girard, Marine Lefevre, Edith Borcoman, Anne-Vincent Salomon, Sylvain Baulande, Helene D Moreau, Christine Sedlik, Claire Hivroz, Ana-Maria Lennon-Duménil, Jimena Tosello, Eliane Piaggio
CD74 supports accumulation and function of regulatory T cells in tumors. Nature communications 15 (1) (2024)
Stephen J Bagley, Zev A Binder, Lamia Lamrani, Eliana Marinari, Arati S Desai, Mac Lean P Nasrallah, Eileen Maloney, Steven Brem, Robert A Lustig, Goldie Kurtz, Michelle Alonso-Basanta, Pierre-Emmanuel Bonte, Christel Goudot, Wilfrid Richer, Eliane Piaggio, Shawn Kothari, Lea Guyonnet, Coralie L Guerin, Joshua J Waterfall, Suyash Mohan, Wei-Ting Hwang, Oliver Y Tang, Meghan Logun, Meghna Bhattacharyya, Kelly Markowitz, Devora Delman, Amy Marshall, E John Wherry, Sebastian Amigorena, Gregory L Beatty, Jennifer L Brogdon, Elizabeth Hexner, Denis Migliorini, Cécile Alanio, Donald M O'Rourke
Repeated peripheral infusions of anti-EGFRvIII CAR T cells in combination with pembrolizumab show no efficacy in glioblastoma: a phase 1 trial. Nature cancer (2024)
Pierre-Emmanuel Bonte, Christina Metoikidou, Sandrine Heurtebise-Chrétien, Yago A Arribas, Aurélien Sutra Del Galy, Mengliang Ye, Leticia Laura Niborski, Elina Zueva, Eliane Piaggio, Agathe Seguin-Givelet, Nicolas Girard, Cécile Alanio, Marianne Burbage, Christel Goudot, Sebastian Amigorena
Selective control of transposable element expression during T cell exhaustion and anti-PD-1 treatment. Science immunology 8 (88) (2023)
Sheila Lopez-Cobo, Jaime R Fuentealba, Paul Gueguen, Pierre-Emmanuel Bonte, Kyriaki Tsalkitzi, Irena Chacon, Salomé Glauzy, Armelle Bohineust, Ariane Biquand, Lisseth Silva, Zelia L Gouveia, Christel Goudot, Franck Perez, Michael Saitakis, Sebastian Amigorena
SUV39H1 Ablation Enhances Long-Term CAR-T Function in Solid Tumors. Cancer discovery (2023)
Reza Naghavian, Wolfgang Faigle, Pietro Oldrati, Jian Wang, Nora C Toussaint, Yuhan Qiu, Gioele Medici, Marcel Wacker, Lena K Freudenmann, Pierre-Emmanuel Bonte, Michael Weller, Luca Regli, Sebastian Amigorena, Hans-Georg Rammensee, Juliane Sarah Walz, Silvio Daniel Brugger, Malte Mohme, Yingdong Zhao, Mireia Sospedra, Marian C Neidert, Roland Martin
Microbial peptides activate tumour-infiltrating lymphocytes in glioblastoma. Nature (2023)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology 24 (1) (2022)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology 24 (1) (2022)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology 24 (1) (2022)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology 24 (1) (2022)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology (2022)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology 24 (1) (2022)
Javiera Paz Villar, Adeline Cros, Alba De Juan, Lamine Alaoui, Pierre-Emmanuel Bonte, Colleen M Lau, Ioanna Tiniakou, Boris Reizis, Elodie Segura
ETV3 and ETV6 enable monocyte differentiation into dendritic cells by repressing macrophage fate commitment. Nature immunology 24 (1) (2022)